ERG TARGETED THERAPY

• 收藏
• 分享

专利权人:

The Regents of the University of Michigan

发明人:

Arul Chinnaiyan,Xiaoju Wang

申请号：

US15924377

公开号：

US20180273595A1

申请日:

2018.03.19

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/